Carmell (NASDAQ:CTCX) Trading Up 2.6% - Here's What Happened

Key Points

• Carmell Co. (NASDAQ:CTCX) shares increased by 2.6% during mid-day trading, reaching a high of $2.69 before settling at $2.61.
• A recent Form 13F filing revealed that Citadel Advisors LLC acquired 187,565 shares of Carmell, representing approximately 0.90% of the company.
• Carmell specializes in bio-aesthetics, utilizing its proprietary Carmell Secretome, which consists of growth factors and proteins extracted from human platelets to support skin and hair health.

Carmell Co. (NASDAQ:CTCX - )'s share price was up 2.6% during mid-day trading on Monday . The stock traded as high as $2.69 and last traded at $2.61. Approximately 10,534 shares traded hands during trading, a decline of 100% from the average daily volume of 4,647,079 shares. The stock had previously closed at $2.54.

Carmell Stock Performance

The firm has a 50-day moving average price of $2.93 and a 200-day moving average price of $1.59.

Institutional Investors Weigh In On Carmell

A hedge fund recently bought a new stake in Carmell stock. Citadel Advisors LLC acquired a new position in Carmell Co. (NASDAQ:CTCX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 187,565 shares of the company's stock, valued at approximately $54,000. Citadel Advisors LLC owned about 0.90% of Carmell as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 24.22% of the company's stock.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.